9:27 AM ET
8-K
Executive Compensation
Biomarin Pharmaceutical Executive Compensation
BioMarin Pharmaceutical Inc. increased its board size from ten to eleven members and appointed Robert Plenge, M.D., Ph.D., as an independent director. Dr. Plenge will receive standard non-employee director fees and was granted restricted stock units (RSUs) valued at $400,000, which vest just prior to the company's next annual meeting.
- Counterparty
- Robert Plenge